Implementation of Molecular Surveillance After a Cluster of Fatal Toxoplasmosis at 2 Neighboring Transplant Centers

Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts

(2015) G S Hobbs et al.   BONE MARROW TRANSPLANTATION

Toxoplasma prophylaxis in haematopoietic cell transplant recipients

(2015) Kiran Gajurel et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Clinical Features and Outcomes in Patients With Disseminated Toxoplasmosis Admitted to Intensive Care: A Multicenter Study

(2013) M. Schmidt et al.   CLINICAL INFECTIOUS DISEASES

A review on human toxoplasmosis

(2012) Geita Saadatnia et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Myeloablative Conditioning Predisposes Patients forToxoplasma gondiiReactivation after Allogeneic Stem Cell Transplantation

(2010) Stef Meers et al.   CLINICAL INFECTIOUS DISEASES

Regionally limited or rare infections: prevention after hematopoietic cell transplantation

(2009) J Gea-Banacloche et al.   BONE MARROW TRANSPLANTATION

Toxoplasmosis: A history of clinical observations

(2009) Louis M. Weiss et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

Diagnosis of Toxoplasmosis after Allogeneic Stem Cell Transplantation: Results of DNA Detection and Serological Techniques

(2008) Hélène Fricker‐Hidalgo et al.   CLINICAL INFECTIOUS DISEASES

Prevention of toxoplasmosis in transplant patients

(2008) F. Derouin et al.   CLINICAL MICROBIOLOGY AND INFECTION